Corvus Pharmaceuticals
CRVS
CRVS
45 hedge funds and large institutions have $237M invested in Corvus Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
45
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.29M | |
| 2 | +$3.05M | |
| 3 | +$3.02M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.38M |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$2.74M | |
| 3 | -$1.74M | |
| 4 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$1.67M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
-$1.63M |